Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Patients on Certain Medications Some medicines can mess with how our bodies absorb or use Vitamin B12, raising the risk of deficiency
Manufactured in accredited laboratories using advanced peptide synthesis methods, each BPC-157 vial is independently batch-tested to verify identity, purity, and consistency
Ive been a member for a while now and its absolutely worth it
Alternate between your abdomen, thigh, and upper arm to reduce irritation and allow each site to recover
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
US$ 28.65
US$ 27.52
US$ 20.13
US$ 21.43
US$ 26.50
US$ 24.93
